Green Leaf Jiaao Pharmaceutical

Green Leaf Jiaao Pharmaceutical (Shijiazhuang) Co., Ltd. is a key subsidiary of Luye Pharma Group, specializing in the research, development, and large-scale manufacturing of advanced pharmaceutical formulations. Based in Shijiazhuang, China, the company focuses on central nervous system (CNS) and oncology therapeutics, leveraging proprietary delivery platforms such as long-acting microspheres and liposomes. The facility serves as a primary production hub for Luye's innovative pipeline, including the FDA-approved Rykindo for schizophrenia and various recombinant protein therapies. By integrating R&D with high-standard GMP manufacturing, Green Leaf Jiaao Pharmaceutical supports the global commercialization of complex injectables and specialty medicines. The company is instrumental in Luye Pharma's strategy to provide high-quality, innovative treatments for chronic and life-threatening conditions worldwide.